Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2026-01-09 00:00:00 ET · period of report 2026-01-08 · accession 0001182473-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-08 | RCUS | ROSEN TERRY J | CEO, Dir | G - Gift | $0.00 | -35.0K | 2.16M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-08 | G | D | 35,000 | $0.00 | 2,157,409 | D | — | — | (F2) Includes the unvested portion of the reporting person's RSU grants. |